HCW Biologics Inc. (HCWB)
0.579
-0.02
(-3.98%)
USD |
NASDAQ |
Feb 20, 16:00
0.5647
-0.01
(-2.47%)
After-Hours: 20:00
HCW Biologics EPS Diluted (Quarterly) : -2.015 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nektar Therapeutics | -1.875 |
| AbbVie, Inc. | 1.024 |
| Q32 Bio, Inc. | -0.6036 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.554M |
| Revenue (Quarterly) | 0.0156M |
| Total Expenses (Quarterly) | 4.570M |
| Enterprise Value | 8.302M |
| Gross Profit Margin (Quarterly) | -1.09K% |
| Profit Margin (Quarterly) | -29.19K% |
| Earnings Yield | -2.41K% |
| Normalized Earnings Yield | -2639.17 |